<div id="readability-page-1" class="page"><div itemprop="articleBody"><p _translation="CDC專家組裁定，醫生明年可以將鼻腔噴霧流感疫苗作為第一道防護措施。">A CDC panel ruled that doctors can use the nasal spray flu vaccine as a first line of protection for children next year.</p><p _translation="在過去的兩年裡，聯邦機構的疫苗諮詢小組拒絕認可噴霧劑。&nbsp;">For the last two years, the federal agency's vaccine advisory panel has refused to endorse the spray.&nbsp;</p><p _translation="一些研究發現，以品牌名稱FluMist聞名的疫苗不能抵抗某些流感毒株。&nbsp;">Some research has found that the vaccine, known by the brand name FluMist, did not protect against certain strains of the flu.&nbsp;</p><p _translation="免疫實踐諮詢委員會周三投票表決，建議將鼻噴霧劑作為下一個冬季流感季節的一個選擇，專家說，今年可能會保護更多的美國人免受疾病的侵襲。">The Advisory Committee of Immunization Practices voted Wednesday to recommend the nasal spray as an option for next winter's flu season, and experts say it might have protected more Americans from illness this year.</p><div><p _translation="一個聯邦小組讓醫生開始在星期三再次開始使用兒童友好的噴鼻流感疫苗（文件圖像）">A federal panel gave the go ahead for doctors to start using the child-friendly nasal spray flu vaccine again on Wednesday (file image)</p></div><p _translation="疾病控制和預防中心已經花費了過去五個月時間，敦促六個月以上的每個人都能得到今年推薦的兩種流感疫苗之一。">The Centers for Disease Control and Prevention has spent the last five months urging everyone over six months of age to get one of the two flu shots it recommended this year.</p><p _translation="但是，正如官員上周宣布的那樣，這個季節每個人對流感的有效性只有36％左右。&nbsp;">But, as officials announced last week, each of these was only about 36 percent effective against the flu this season.&nbsp;</p><p _translation="對2017-2018賽季占主導地位的攻擊性H3N2菌株的防禦力特別弱，防止只有25％的成蟲獲得該蟲。&nbsp;&nbsp;">The shots were particularly weak protection against the aggressive H3N2 strain that has dominated the 2017-2018 season, preventing only 25 percent of adults from getting the bug.&nbsp;&nbsp;</p><p _translation="這個鏡頭在保護兒童方面有點更好 - 大約有59％的效果 - 儘管他們無疑更喜歡噴霧劑。&nbsp;">The shot was somewhat better at protecting children - about 59 percent effective - though they undoubtedly would prefer the spray.&nbsp;</p><p _translation="與大多數國家不同，本季美國推薦的流感疫苗都不含流感減毒流感病毒（LAIV），它是FluMist的活性成分。&nbsp;&nbsp;&nbsp;&nbsp;">Unlike most countries, neither of the flu shots recommended in the US this season contained any live attenuated influenza virus (LAIV), the active ingredient in FluMist.&nbsp;&nbsp;&nbsp;&nbsp;</p><p _translation="FluMist是美國唯一獲得批准的鼻腔噴霧疫苗，近年來發現其效果相對較差，特別是針對2015  -  2016年期間導致大多數疾病的H1N1流感病毒株。">FluMist, the only nasal spray vaccine approved in the US, was found to be relatively ineffective in recent years, particularly against the H1N1 strain of the flu that was responsible for the majority of illnesses during the 2015-2016 season.</p><p _translation="為了讓活的病毒疫苗對人類使用安全有效，它必須在復制足夠的激活免疫反應之間取得恰當的平衡，但不足以導致疾病本身。&nbsp;">In order for a live virus vaccine to be safe and effective for use humans, it has to strike just the right balance between replicating enough to activate an immune response, but not enough to cause the illness itself.&nbsp;</p><p _translation="FluMist過去對H1N1的不良表現可能意味著製造疫苗的阿斯利康公司的科學家們挑選了太弱的蛋白質。&nbsp;">FluMist's past poor performance against H1N1 may mean that scientists at AstraZeneca, which makes the vaccine, picked proteins that were too weak.&nbsp;</p><p _translation="該公司在今天的會議上將一項小型研究的數據提交給免疫實踐諮詢委員會。&nbsp;">The company presented a data from a small study to the&nbsp;Advisory Committee of Immunization Practices during its meeting today.&nbsp;</p><mol-permabox id="mol-70e11440-1758-11e8-849f-f5cedd37c7f0"><div data-version="2" id="mol-9ed0aea0-f7bf-11e7-b2bb-4dde7e915dd1" data-permabox-url="/health/fb-5263787/WHAT-FLU-STRAINS-HITTING-YEAR.html"><h3 _translation="這一年流行性感冒是什麼造成的？">WHAT ARE THE FLU STRAINS HITTING THE US THIS YEAR?</h3><div><p _translation="世界各地有許多不同類型的流感流行，但今年冬天美國將出現四種主要類型，或將出現在美國。">There are many different types of flu circulating around the world, but four main types are being seen, or are set to emerge, in America this winter.</p><p _translation="H3N2 - 去年冬天在澳大利亞襲擊澳大利亞後被稱為“澳大利亞流感”，這種毒株更可能影響老年人，而老年人對目前的疫苗反應不佳。這是今年冬季迄今為止最常見的菌株之一。"><span>H3N2 </span>- Dubbed 'Aussie flu' after it struck Australia hard last winter, this strain is more likely to affect the elderly, who do not respond well to the current vaccine. This is one of the most common strains seen so far this winter.</p><p _translation="H1N1 - 這種菌株 - 被稱為“豬流感” - 通常更可能對兒童造成傷害，這些兒童對疫苗接種反應良好。今年到目前為止，這個數字幾乎和H3N2一樣多。過去它只是經常從豬身上發現，但是在2009年發生了變化，當時它在全球重大流行病的人類中迅速傳播。"><span>H1N1 </span>- This strain – known as 'swine flu' - is generally more likely to hit children, who respond well to vaccination. This has been seen nearly as often as H3N2 so far this year. In the past it was only commonly caught from pigs, but that changed in 2009 when it started spreading rapidly among humans in a major global pandemic.</p><p _translation="B / Yamagata - 這就是所謂的'日本流感'。只有接受過四種疫苗的人才能免受山形病毒的侵襲，這種疫苗在今年冬天第一次被引入後正在緩慢推出。那些接受正常'三毒株'疫苗的人不受保護。"><span>B / Yamagata </span>- This is known as 'Japanese flu'. Only people who received the 'four strain' vaccine - which is being slowly rolled out after it was introduced for the first time this winter - are protected against the Yamagata strain. Those who received the normal 'three strain' vaccine are not protected.</p><p _translation="B /維多利亞州 - 這種菌株在正常的'三株'疫苗中接種疫苗，但今年冬天至今尚未出現，僅有四例確診病例。"><span>B / Victoria </span>- This strain is vaccinated against in the normal 'three strain' vaccine, but has hardly appeared so far this winter, with just four confirmed cases.</p> </div></div></mol-permabox><p _translation="約翰霍普金斯大學免疫學教授Andrew Pekosz博士說：“他們可能以某種方式修復了H1N1病毒[可能是通過]選擇了特定LAIV中使用的蛋白質，這些蛋白質的複制效果更好。”">'They probably fixed the H1N1 component in some way, [possibly by] picking proteins used in this particular LAIV that replicated better,' says Dr Andrew Pekosz, a Johns Hopkins University immunology professor who has studied the spray.</p><p _translation="即使是最重要的專家也很難預測每個季節會出現什麼樣的流感病毒，而純粹的巧合是H1N1不會在最近兩個季節出現。">It is difficult for even the foremost experts to predict what strains of the flu will strike each season, and pure coincidence that H1N1 did not come around the last two seasons.</p><p _translation="但是，在過去的兩年中，當[FluMist]沒有上市時，我們已經擁有了H3N2，噴霧劑本應該善於“防護”，Pekosz博士說。&nbsp;&nbsp;">But, 'for the last two years when [FluMist] was not on the market, we've had H3N2, something [the spray] should have been good at' protecting against, Dr Pekosz says.&nbsp;&nbsp;</p><p _translation="“正在流行的流感菌株是LAIV一直在努力的流感菌株，所以它可能會在過去兩個季度幫助我們，”他補充道。">'The strains of flu that are circulating are the ones that an LAIV has been working well for, so it probably would have helped us these last two seasons,' he adds.</p><p _translation="他指出，噴霧劑在CDC為成人和兩歲以上兒童推薦的年份裡，'噴灑'廣泛用於兒科患者'。&nbsp;&nbsp;">He notes that the spray was 'utilized extensively in pediatric patients' during years when it was recommended by the CDC for adults and children over two.&nbsp;&nbsp;</p><p _translation="今年迄今已有84名兒童死亡，預計會有更多人死於流感。&nbsp;">This year, 84 children have died so far, and more are expected to succumb to the flu.&nbsp;</p><p _translation="Pekosz說，小孩和大人都更容易接受流感噴霧劑，因為它不涉及&nbsp;">Both children and adults are anecdotally more likely to accept the flu spray, says Pekosz, because it does not involve&nbsp;</p><p _translation="鼻腔噴霧疫苗還可以對流感發作時身體各部位直接提供更快的保護。">The nasal spray vaccine can also offer faster protection directly to the parts of the body the flu attacks.</p><p _translation="“射擊”在你的手臂中激活，並在血液中產生反應，但我們真正想要做的是在病毒進入人體的表面產生免疫反應。">The shot 'activates in your arm, and generates a response in your blood, but what we really want to do is generate an immune response at the surface where [the virus] enters the body.</p><p _translation="“這就是FluMist做得非常好的原因：它會在你的呼吸道產生黏膜反應，”我們通常會吸入流感病毒，Pekosz博士說。&nbsp;">'That's what the FluMist does really well: it induces a mucosal response in your respiratory tract,' where we typically inhale the flu virus, Dr Pekosz says.&nbsp;</p><p _translation="出於這個原因，鼻噴霧劑“首先可能會更好地阻止流感病毒，”他補充說。&nbsp;">For this reason the nasal spray is 'probably going to be a little better at stopping the flu virus in the first place,' he adds.&nbsp;</p><p _translation="“這是很難預測的，但我們通常沒有看到兩個流感季節有相同的壓力，所以明年可能會對H1N1病毒造成很大影響，所以擁有一種對H1N1有效的LAIV，”他希望FluMist會現在是'，明年是預防流行性感冒的好工具，“Pekosz博士說。&nbsp;&nbsp;">'It is difficult to predict, but we usually don't see two flu seasons with the same strain, so next year is probably going to be heavy on H1N1, so having an LAIV that is effective against H1N1,' as he hopes FluMist will now be, 'is a great tool to have against influenza next year,' Dr Pekosz says.&nbsp;&nbsp;</p></div></div>